Registry of Lobbyists
Subject matters | Details | Categories |
---|---|---|
Health,
Science and Technology
|
Conversations regarding the challenges that Canadian life sciences and biomanufacturing companies face in accessing capital for biomanufacturing purposes.
|
Policies or Program
|
Health,
Science and Technology
|
Conversations regarding the importance of quality assurance and accuracy in point-of-care testing, sexually transmitted infections and cancer screening, and the federal biomanufacturing strategy.
|
Policies or Program
|
Subject matters | Details | Categories |
---|---|---|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Bill C-13, an Act respecting certain measures in response to COVID-19.
|
Legislative Proposal, Bill or Resolution
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Conversations regarding the challenges that Canadian life sciences and biomanufacturing companies face in accessing capital for biomanufacturing purposes.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Conversations regarding the importance of quality assurance and accuracy in point-of-care testing, sexually transmitted infections and cancer screening, and the federal biomanufacturing strategy.
|
Policies or Program
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Date | DPOH, Position Title | Government Institution | Subject Matters |
---|---|---|
2024-01-29 |
|
Health, Science and Technology |
2024-01-29 |
|
Health |
2023-09-27 |
|
Health, Science and Technology |